|Title:||Bone marrow plasma level of decorin may be associated with improved treatment outcomes in a subset of multiple myeloma patients||Authors:||Huang, Shang-Yi
|Keywords:||Decorin; Extracellular matrix; Hepatocyte growth factor; Mesenchymal stem cell; Myeloma||Issue Date:||Mar-2022||Journal Volume:||121||Journal Issue:||3||Source:||Journal of the Formosan Medical Association = Taiwan yi zhi||Abstract:||
Decorin is a small leucine-rich proteoglycan rich in extracellular matrix with potential antitumor activity. However, the role of decorin in hematological malignancies remains unclear, especially in the case of multiple myeloma (MM), a bone marrow (BM) stroma-dependent plasma cell neoplasm.
|Appears in Collections:||醫學院附設醫院 (臺大醫院)|
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.